DVS

DVS

Home
Notes
Now
Tools
Archive
About
Revisiting What We Missed in Landmark Epidemiological Studies
Hunting for overlooked insights in their findings and datasets with the latest AI tools
 • 
David Van Sickle
London highlights & May favorites
Plus, companies as creative acts, and promising new respiratory drugs
 • 
David Van Sickle
Human curiosity as AI naturalist guide
Perplexing observations and productive holes in science
 • 
David Van Sickle
Healthtech vs Pulmonary Fibrosis
A quick profile of two companies working on IPF/PF
 • 
David Van Sickle
Respiratory Healthtech Companies
An informal inventory of what's in the market today
 • 
David Van Sickle
Equity Prerequisite
Demands for accessible and equitable digital respiratory health are premature and counterproductive
 • 
David Van Sickle
Stuff making it feel like spring in February
Seriously, it is 50+ degrees here and the ice is almost gone
 • 
David Van Sickle
Digital Health vs the Causes of Incidence
We need comparative research at scale to move things forward
 • 
David Van Sickle
Digital health mafia departures
Making sense of company identity and individual careers
 • 
David Van Sickle
DVS
DVS
I write about my experience building and selling a health technology company, and about how to invest in, advise, and support awesome entrepreneurs.
Recommendations
View all 18
Ground Truths
Ground Truths
Eric Topol
The Honest Broker
The Honest Broker
Ted Gioia
Lenny's Newsletter
Lenny's Newsletter
Lenny Rachitsky
The Century of Biology
The Century of Biology
Elliot Hershberg
Austin Kleon
Austin Kleon
Austin Kleon
projects
I'm writing a workbook for startup acquisitions
Add your name and I'll let you know when it's ready
Respiratory Healthtech Companies
An informal database of what's in the market today
© 2025 David Van Sickle
Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture